相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex
Michal Yalon et al.
CHILDS NERVOUS SYSTEM (2011)
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors
Hiu-yan Chan et al.
ADVANCES IN THERAPY (2010)
Rapamycin-Insensitive Up-Regulation of MMP2 and Other Genes in Tuberous Sclerosis Complex 2-Deficient Lymphangioleiomyomatosis-Like Cells
Po-Shun Lee et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
The tuberous sclerosis complex
Ksenia A. Orlova et al.
YEAR IN NEUROLOGY 2 (2010)
Sirolimus and tuberous sclerosis-associated renal angiomyolipomas
L. Krischock et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2010)
Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells
Samy L. Habib et al.
CARCINOGENESIS (2010)
Tuberous sclerosis complex: a brave new world?
Kevin C. Ess
CURRENT OPINION IN NEUROLOGY (2010)
Metformin and cancer: licence to heal?
Nikolaos Papanas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
Margot G. F. van Lier et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
AMPK as a mediator of hormonal signalling
Chung Thong Lim et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors
Chelsey Woodrum et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
mTORC1 Directly Phosphorylates and Regulates Human MAF1
Annemieke A. Michels et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
MicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
Jakub Godlewski et al.
MOLECULAR CELL (2010)
Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex
Ramon Peces et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rapamycin (Sirolimus) in Tuberous Sclerosis Associated Pediatric Central Nervous System Tumors
Catherine Lam et al.
PEDIATRIC BLOOD & CANCER (2010)
Optic Nerve Tumor in Tuberous Sclerosis Complex is not Responsive to Sirolimus
Steven P. Sparagana et al.
PEDIATRIC NEUROLOGY (2010)
mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1
Theodoros Kantidakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity
Michael Haidinger et al.
TRANSPLANT INTERNATIONAL (2010)
Fibroblasts From Normal Skin of a Tuberous Sclerosis Patient Show Upregulation of mTOR Pathway
Jaroslaw Jozwiak et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2009)
Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model
Chongjuan Wei et al.
CANCER LETTERS (2009)
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
Dorota Dworakowska et al.
ENDOCRINE-RELATED CANCER (2009)
Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction
Yasumasa Ikeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Rapamycin Reduces Seizure Frequency in Tuberous Sclerosis Complex
Jennifer Muncy et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Ruifang Mi et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Oral rapamycin reduces tumour burden and vascularization in Lkb1+/- mice
James Robinson et al.
JOURNAL OF PATHOLOGY (2009)
Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation
Afshan McCarthy et al.
JOURNAL OF PATHOLOGY (2009)
Nutrient-dependent mTORC1 Association with the ULK1-Atg13-FIP200 Complex Required for Autophagy
Nao Hosokawa et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Chang Hwa Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
Kristen Pollizzi et al.
MOLECULAR CANCER (2009)
LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism
Marnix Jansen et al.
PHYSIOLOGICAL REVIEWS (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rapamycin as a Therapy of Choice After Renal Transplantation in a Patient With Tuberous Sclerosis Complex
A. Tarasewicz et al.
TRANSPLANTATION PROCEEDINGS (2009)
Neurofibroma development in NF1-insights into tumour initiation
Simona Parrinello et al.
TRENDS IN CELL BIOLOGY (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
Ling-Hui Zeng et al.
ANNALS OF NEUROLOGY (2008)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
G. F. L. Hofbauer et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas
Cristina M. Contreras et al.
CANCER RESEARCH (2008)
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin
Cristiane H. Squarize et al.
CANCER RESEARCH (2008)
Lkb1 deficiency causes prostate neoplasia in the mouse
Helen B. Pearson et al.
CANCER RESEARCH (2008)
LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis
Sushma Gurumurthy et al.
CANCER RESEARCH (2008)
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma
Balazs Hegedus et al.
CANCER RESEARCH (2008)
Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling
Chongjuan Wei et al.
CLINICAL CANCER RESEARCH (2008)
TORC1 is essential for NF1-associated malignancies
Cory M. Johannessen et al.
CURRENT BIOLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex
Mary Kay Koenig et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function
Lynsey Meikle et al.
JOURNAL OF NEUROSCIENCE (2008)
Pancreatic Lkb1 deletion leads to acinar polarity defects and cystic neoplasms
Aram F. Hezel et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
STRAD alpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7
Julia Dorfman et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners
Margit Rosner et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis
Pekka Katajisto et al.
NATURE GENETICS (2008)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
D. Mark Davies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
LKB1; linking cell structure and tumor suppression
A. F. Hezel et al.
ONCOGENE (2008)
Hamartomatous polyposis syndromes
Daniel Calva et al.
SURGICAL CLINICS OF NORTH AMERICA (2008)
Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages
Alf Corsenca et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Tuberous sclerosis complex:: Advances in diagnosis, genetics, and management
Robert A. Schwartz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
J. Carretero et al.
ONCOGENE (2007)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex
Isabelle Herry et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
The role of leukotriene receptor signaling in inflammation and cancer
Ramin Massoumi et al.
THESCIENTIFICWORLDJOURNAL (2007)
Combination of a rapamycin analog (CCI-779) and interferon-γ is more effective than single agents in treating a mouse model of tuberous sclerosis complex
Laifong Lee et al.
GENES CHROMOSOMES & CANCER (2006)
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth
Ken Inoki et al.
CELL (2006)
Expanding role of AMPK in endocrinology
Blerina Kola et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase
H Chong-Kopera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
DN Franz et al.
ANNALS OF NEUROLOGY (2006)
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex
Ralf Wienecke et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Peutz-Jeghers syndrome: clinicopathology and molecular alterations
T. J. McGarrity et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Rapamycin: An anti-cancer immunosuppressant?
BK Law
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Regulation of mTOR and cell growth in response to energy stress by REDD1
A Sofer et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer:: The role of promoter methylation of TSC genes
WG Jiang et al.
EUROPEAN JOURNAL OF CANCER (2005)
Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting:: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex
O Sancak et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Efficacy of a rapamycin analog (CCI-779) and IFN-γ in tuberous sclerosis mouse models
L Lee et al.
GENES CHROMOSOMES & CANCER (2005)
Signaling by target of rapamycin proteins in cell growth control
K Inoki et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate
M Jaleel et al.
FEBS LETTERS (2005)
Effects of rapamycin in the Eker rat model of tuberous sclerosis complex
H Kenerson et al.
PEDIATRIC RESEARCH (2005)
Comprehensive proteomic analysis of human par protein complexes reveals an interconnected protein network
M Brajenovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation
EJ Uhlmann et al.
GLIA (2004)
Lessons from the eker rat model: From cage to bedside
RS Yeung
CURRENT MOLECULAR MEDICINE (2004)
The biology and clinical relevance of the PTEN tumor suppressor pathway
I Sansal et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Multistep renal carcinogenesis in the eker (Tsc 2 gene mutant) rat model
O Hino
CURRENT MOLECULAR MEDICINE (2004)
The eker rat: Establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma
JD Cook et al.
CURRENT MOLECULAR MEDICINE (2004)
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytornas:: Biallelic inactivation of TSC1 or TSC2 leads to rnTOR activation
JA Chan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
MN Corradetti et al.
GENES & DEVELOPMENT (2004)
mTOR cascade activation distinguishes tubers from focal cortical dysplasia
M Baybis et al.
ANNALS OF NEUROLOGY (2004)
Insulin signaling pathways in cortical dysplasia and TSC-tubers: Tissue microarray analysis
H Miyata et al.
ANNALS OF NEUROLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm
J Boudeau et al.
EMBO JOURNAL (2003)
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
HB Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1
J Spicer et al.
ONCOGENE (2003)
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD
AF Baas et al.
EMBO JOURNAL (2003)
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Y Zhang et al.
NATURE CELL BIOLOGY (2003)
Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours
MA Knowles et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Rapamycins - Mechanism of action and cellular resistance
SL Huang et al.
CANCER BIOLOGY & THERAPY (2003)
Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway
H Onda et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures
EJ Uhlmann et al.
ANNALS OF NEUROLOGY (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
LKB1 - A master tumour suppressor of the small intestine and beyond
LI Yoo et al.
NATURE REVIEWS CANCER (2002)
Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis
K Jishage et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
DJ Kwiatkowski et al.
HUMAN MOLECULAR GENETICS (2002)
Mammalian TOR: A homeostatic ATP sensor
PB Dennis et al.
SCIENCE (2001)
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice
K Podsypanina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice
A Ylikorkala et al.
SCIENCE (2001)
The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
G Benvenuto et al.
ONCOGENE (2000)
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
T Carsillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
